phase iii combi-d study of dabrafenib and trametinib in patients with melanoma
Published 8 years ago • 1.1K plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
3:06
combi-d: phase 3 trial of dabrafenib plus trametinib in braf v600e/k-mutated melanoma
-
2:08
phase 3 combi-d trial of dabrafenib plus trametinib in metastatic
-
1:27
bgb324 with pembrolizumab or dabrafenib/trametinib in melanoma
-
1:40
dr. robert on the phase iii combi-v study in braf-mutant melanoma
-
2:09
combi-d: a phase iii study on the combination of dabrafenib and trametinib in patients with melanoma
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
-
1:42
dr. jason luke describes results from the phase iii combi-d trial
-
4:08
updates from combi-ad: dabrafenib and trametinib for melanoma
-
0:53
dabrafenib plus trametinib demonstrates benefit in braf-mutant melanoma
-
1:24
adverse events with dabrafenib/trametinib combination in melanoma
-
1:19
dr. robert on potential of dabrafenib/trametinib in melanoma brain metastases
-
1:24
adverse events with dabrafenib/trametinib combination in melanoma
-
1:33
dr. robert on next steps following the phase iii combi-v study in melanoma
-
3:05
dabrafenib and trametinib: a promising combination for the treatment of melanoma
-
2:11
dr. georgina long on dabrafenib and trametinib in braf-mutated melanoma
-
1:49
combi-ad: dabrafenib plus trametinib in advanced melanoma
-
6:39
combi-d: phase iii dabrafenib trametinib vs. dabrafenib ...
-
4:45
combi-ad trial: adjuvant dabrafenib plus trametinib in patients with resected stage iii braf v60...
-
1:03
five-year os data for dabrafenib/trametinib combo in melanoma